Cargando…
Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?
Favourable regulatory assessments, liberal policy changes, new research centres and substantial commercial investment signal that psychedelic therapy is making a major comeback. Positive findings from modern trials are catalysing developments, but it is questionable whether current confirmatory tria...
Autores principales: | Carhart-Harris, Robin L, Wagner, Anne C, Agrawal, Manish, Kettner, Hannes, Rosenbaum, Jerold F, Gazzaley, Adam, Nutt, David J, Erritzoe, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801625/ https://www.ncbi.nlm.nih.gov/pubmed/33888025 http://dx.doi.org/10.1177/02698811211008567 |
Ejemplares similares
-
Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey
por: Kuc, Joanna, et al.
Publicado: (2021) -
Psychedelics and health behaviour change
por: Teixeira, Pedro J, et al.
Publicado: (2021) -
The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2023) -
Antidepressant effects of a psychedelic experience in a large
prospective naturalistic sample
por: Nygart, Victoria Amalie, et al.
Publicado: (2022) -
Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample
por: Mans, Keri, et al.
Publicado: (2021)